论文信息 - GPCRs: Heterodimer-specific signaling.

GPCRs: Heterodimer-specific signaling.

Heterodimerization of G protein–coupled receptors can lead to the activation of intracellular pathways that are not triggered by either of the individual receptors. This property may lead to the development of new therapeutic approaches showcasing increased efficiency and selectivity.

Marc Parmentier | M. Parmentier

[1] P. Gmeiner,et al. Class A G-protein-coupled receptor (GPCR) dimers and bivalent ligands. , 2013, Journal of medicinal chemistry.

[2] Robert DeRose,et al. Manipulating signaling at will: chemically-inducible dimerization (CID) techniques resolve problems in cell biology , 2013, Pflügers Archiv - European Journal of Physiology.

[3] D. Moura,et al. Involvement of G-protein βγ subunits on the influence of inhibitory α2-autoreceptors on the angiotensin AT1-receptor modulation of noradrenaline release in the rat vas deferens , 2006, Neurochemistry International.

[4] Jamie Fong,et al. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5] B. O'dowd,et al. D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum , 2007, Proceedings of the National Academy of Sciences.

[6] M. Lohse. Dimerization in GPCR mobility and signaling. , 2010, Current opinion in pharmacology.

[7] Céline Galés,et al. Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling. , 2015, Nature chemical biology.

[8] Michel Bouvier,et al. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers , 2007, Pharmacological Reviews.